| Azacitidine for front-line therapy of patients with AML: reproducible efficacy established by direct comparison of international phase 3 trial data with registry data from the … L Pleyer, H Döhner, H Dombret, JF Seymour, AC Schuh, CL Beach, ... International journal of molecular sciences 18 (2), 415, 2017 | 69 | 2017 |
| Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization … L Pleyer, S Burgstaller, R Stauder, M Girschikofsky, H Sill, K Schlick, ... Journal of Hematology & Oncology 9, 1-16, 2016 | 45 | 2016 |
| Acute graft versus host disease after orthotopic liver transplantation IM Rogulj, J Deeg, SJ Lee Journal of hematology & oncology 5, 1-6, 2012 | 45 | 2012 |
| The role of microRNA in myelodysplastic syndromes: beyond DNA methylation and histone modification V Milunović, I Mandac Rogulj, A Planinc‐Peraica, E Bulycheva, ... European journal of haematology 96 (6), 553-563, 2016 | 23 | 2016 |
| Bendamustine: an old drug in the new era for patients with non-hodgkin lymphomas and chronic lymphocytic leukemia M Bogeljić Patekar, V Milunović, K Mišura Jakobac, D Perica, ... Acta Clinica Croatica 57 (3.), 542-553, 2018 | 20 | 2018 |
| Lenalidomide induced good clinical response in a patient with multiple relapsed and refractory Hodgkin's lymphoma I Mandac, SO Kolonic Journal of hematology & oncology 3, 1-3, 2010 | 17 | 2010 |
| The effect of body position on intraocular and CSF pressures in the lateral ventricle, and in cortical and lumbar subarachnoid spaces in cats T Kuzman, I Jurjević, I Mandac, M Radoš, D Orešković, H Jednačak, ... Intracranial Pressure and Brain Monitoring XIV, 357-361, 2012 | 15 | 2012 |
| Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective T De Witte, L Malcovati, P Fenaux, D Bowen, A Symeonidis, M Mittelman, ... haematologica 105 (11), 2516, 2020 | 14 | 2020 |
| Frontline treatment with the combination obinutuzumab±chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by … Y Herishanu, A Shaulov, R Fineman, S Bašić‐Kinda, A Aviv, ... American journal of hematology 95 (6), 604-611, 2020 | 14 | 2020 |
| Smjernice za dijagnozu i liječenje bolesnika s mijelodisplastičnim sindromom N Gredelj Šimec, G Kaić, A Škrtić, Z Šiftar, R Lasan-Trčić, T Valković, ... Liječnički vjesnik 139 (1-2), 0-0, 2017 | 14 | 2017 |
| Smjernice Hrvatskog društva za hematologiju HLZ-a i KROHEM-a za zbrinjavanje anemije uzrokovane manjkom željeza I Radman, M Vodanović, I Mandac-Rogulj, J Roganović, T Valković, ... Liječnički vjesnik 141 (1-2), 1-13, 2019 | 12 | 2019 |
| Alterations within the osteo-hematopoietic niche in MDS and their therapeutic implications A Mies, E Bulycheva, I Mandac Rogulj, L C Hofbauer, U Platzbecker Current Pharmaceutical Design 22 (16), 2323-2332, 2016 | 10 | 2016 |
| FDA's and EMA's approval of brentuximab vedotin for advanced Hodgkin lymphoma: Another player in the town? V Milunović, K Mišura Jakobac, M Kursar, I Mandac Rogulj, ... European journal of haematology 103 (3), 145-151, 2019 | 9 | 2019 |
| Azacitidine in acute myeloid leukemia with> 30% bone marrow blasts and< 15 G/L white blood cell count: results from the Austrian Azacitidine Registry of the AGMT study group … L Pleyer, S Burgstaller, R Stauder, M Girschikofsky, H Sill, K Schlick, ... Blood 126 (23), 2515, 2015 | 9 | 2015 |
| Dasatinib-induced nephrotic syndrome: a case of phenoconversion? I Mandac Rogulj, V Matišić, B Arsov, L Boban, A Juginović, V Molnar, ... Croatian medical journal 60 (3), 250-254, 2019 | 8 | 2019 |
| Septic arthritis due to Streptococcus sanguis I Mandac, I Prkačin, M Sabljar Matovinović, D Šušterčić Collegium antropologicum 34 (2), 661-664, 2010 | 8 | 2010 |
| Is there any Role for Splenectomy in Adulthood Onset Chronic Immun e Thrombocytopenia in the Era of TPO Receptors Agonists? A Critic al Overview M Vibor, I Mandac Rogulj, S Kolonic Ostojic Cardiovascular & Haematological Disorders-Drug Targets (Formerly Current …, 2017 | 7 | 2017 |
| Is it time to redefine response in elderly patients with WHO-acute myeloid leukemia (AML) unfit for intensive chemotherapy? L Pleyer, S Burgstaller, R Stauder, M Girschikofsky, H Sill, K Schlick, ... Blood 126 (23), 3742, 2015 | 6 | 2015 |
| Multiple myeloma in a patient with chronic lymphocytic leukemia--case report and literature review IM Rogulj, D Radić-Kristo, V Milunović, SO Kolonić, B Jelić-Puskarić, ... Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 65 …, 2011 | 6 | 2011 |
| Extramedullary multiple myeloma of the colon--case presentation and literature review IM Rogulj, B Aćamović, T Filipec-Kanizaj, S Gasparov, D Radić-Kristo, ... Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 65 …, 2011 | 6 | 2011 |
Slobodanka Ostojić Kolonićprofesor Medicinski fakultet, Sveučilište ZagrebVerified email at net.hr
